N-Heterocyclic Carbenes
FULL PAPER
(8 mL). H2O2 (30%, 157 mL, 1.788 mmol, 2.0 equiv) was added and the
reaction mixture was stirred overnight at room temperature. The volatiles
were evaporated and the residue was dried in vacuo. Yield: 507 mg
(96%); 1H NMR ([D6]DMSO, 300 MHz): d=2.18 (s, 12H; CH3), 2.33 (s,
6H; CH3), 7.37 (d, 4H; arom.), 7.68 (d, 4H; arom.), 7.74 (s, 4H; arom.),
8.33 (s, 2H; NCHCHN), 9.75 ppm (s, 1H; CH); 13C NMR ([D6]DMSO,
75 MHz): d=17.2, 20.8, 123.7, 124.2, 124.4, 130.2, 135.0, 136.6, 138.7,
141.6, 142.2, 148.8 ppm.
(69%); 1H NMR (CDCl3, 500 MHz): d=1.17–1.35 (m, 4H; cod CH2),
1.20 (t, 12H; CH3), 1.66–1.76 (m, 4H; cod CH2), 2.11 (s, 6H; CH3), 2.34
(s, 6H; CH3), 3.08 (m, 2H; cod CH), 3.32–3.44 (m, 8H; NCH2), 4.12 (m,
2H; cod CH), 6.42 (s, 2H; arom.), 6.46 (s, 2H; arom.), 6.92 ppm (s, 2H;
NCHCHN); 13C NMR (CDCl3, 125 MHz): d=11.6, 17.8, 19.3, 28.0, 32.6,
43.4, 50.0, 80.2, 109.1, 110.6, 122.6, 126.5, 134.3, 137.0, 146.6, 180.7 ppm.
A
(cod)
U
U
U
0.027 mmol, 1.0 equiv), KOtBu (6.1 mg, 0.054 mmol, 2.0 equiv), and N,N’-
bis(2,6-dimethyl-4-dodecyloxyphenyl)imidazolinium chloride (34 mg,
0.049 mmol, 1.8 equiv). Workup procedure A was followed. Yield: 30 mg
N,N’-Bis(2,6-dimethyl-4-tolylsulfinylphenyl)imidazolinium
chloride
(19s·H+): N,N’-Bis(2,6-dimethyl-4-tolylthiophenyl)imidazolium chloride
(293 mg, 0.524 mmol, 1.0 equiv) was dissolved in glacial acetic acid
(10 mL). H2O2 (30%, 110 mL, 1.074 mmol, 2.0 equiv) was added and the
reaction mixture was stirred overnight at room temperature. The volatiles
were evaporated and the residue dried in vacuo. Yield: 312 mg (99%);
1H NMR ([D6]DMSO, 300 MHz): d=2.30 (s, 12H; CH3), 2.33 (s, 6H;
CH3), 4.44 (s, 4H; NCH2CH2N), 7.05 (s, 4H; arom.), 7.26 (d, 4H; arom.),
7.35 (d, 4H; arom.), 9.07 ppm (s, 1H; CH); 13C NMR ([D6]DMSO,
75 MHz): d=17.3, 20.7, 50.8, 124.2, 128.1, 128.6, 130.5, 131.6, 13.2, 136.9,
138.6, 139.2 ppm.
1
(61%); H NMR (CDCl3, 500 MHz): d=0.88 (t, 6H; CH3), 1.24–1.36 (m,
36H; CH2), 1.44–1.46 (m, 4H; cod CH2), 1.64–1.65 (m, 4H; CH2), 1.76–
1.79 (m, 4H; cod CH2), 2.34 (s, 6H; CH3), 2.55 (s, 6H; CH3), 3.08–3.09
(m, 2H; cod CH), 3.88 (s, 4H; NCH2CH2N), 3.94–3.98 (t, 4H; OCH2),
4.11 (m, 2H; cod CH), 6.66 (d, 2H; arom.), 6.68 ppm (d, 2H; arom.);
13C NMR (CDCl3, 125 MHz): d=13.1, 17.7, 19.3, 21.7, 25.0, 27.7, 28.3,
28.3, 28.4, 28.6, 28.6, 28.6, 28.7, 30.9, 32.5, 50.3, 50.9, 67.0, 82.6, 112.8,
113.1, 130.7, 135.7, 138.6, 157.3, 207.0 ppm.
A
(cod)
U
G
N
N,N’-Bis(2,6-dimethyl-4-tolylsulfonylphenyl)imidazolium
chloride
(20u·H+): N,N’-Bis(2,6-dimethyl-4-tolylthiophenyl)imidazolium chloride
(1.00 mg, 1.79 mmol, 1.0 equiv) was dissolved in glacial acetic acid
(40 mL). H2O2 (30%, 3.2 mL, 31.4 mmol, 17.6 equiv) was added and the
reaction mixture was stirred for 2 d at room temperature. The volatiles
were evaporated and the residue dried in vacuo. Yield: 1.11 g (99%);
1H NMR ([D6]DMSO, 300 MHz): d=2.22 (s, 12H; CH3), 2.38 (s, 6H;
CH3), 7.46 (d, 4H; arom.), 7.92 (d, 4H; arom.), 8.01 (s, 4H; arom. CH),
8.36 (d, 2H; NCHCHN), 9.88 ppm (t, 1H; CH); 13C NMR ([D6]DMSO,
75 MHz): d=17.2, 21.0, 124.3, 127.3, 127.7, 130.3, 137.1, 137.2, 137.5,
138.7, 143.4, 144.9 ppm.
0.067 mmol, 1.8 equiv). Workup procedure A was followed. Yield: 40 mg
(61%); H NMR (CDCl3, 500 MHz): d=0.88 (t, 6H; CH3), 1.25–1.37 (m,
1
36H; CH2), 1.45–1.50 (m, 4H; cod CH2), 1.64–1.76 (m, 4H; CH2), 1.77–
1.83 (m, 4H; cod CH2), 2.15 (s, 6H; CH3), 2.36 (s, 6H; CH3), 2.97 (m,
2H; cod CH), 3.97–4.01 (m, 2H; cod CH), 4.16 (t, 4H; OCH2), 6.69 (s,
2H; arom.), 6.71 (s, 2H; arom.), 7.26 ppm (s, 2H; NCHCHN); 13C NMR
(CDCl3, 125 MHz): d=13.1, 17.5, 19.1, 21.7, 25.0, 25.9, 28.0, 28.3, 28.3,
28.4, 28.6, 28.6, 28.7, 30.9, 32.6, 50.3, 67.1, 81.5, 112.5, 112.9, 122.5, 130.5,
134.9, 137.9, 157.9, 180.5 ppm.
A
(cod)
U
G
A
N,N’-Bis(2,6-dimethyl-4-tolylsulfonylphenyl)imidazolinium
chloride
(20s·H+): N,N’-Bis(2,6-dimethyl-4-tolylthiophenyl)imidazolinium chlo-
ride (1.00 mg, 1.79 mmol, 1.0 equiv) was dissolved in glacial acetic acid
(40 mL). H2O2 (30%, 3.2 mL, 31.4 mmol, 17.6 equiv) was added and the
reaction mixture was stirred for 2 d at room temperature. The volatiles
were evaporated and the residue dried in vacuo. Yield: 1.11 g (99%);
1H NMR ([D6]DMSO, 300 MHz): d=2.36 (s, 6H; CH3), 2.45 (s, 12H;
CH3), 4.50 (s, 4H; NCH2CH2N), 7.43 (d, 4H; arom.), 7.86–7.89 (m, 8H;
arom.), 9.14 ppm (s, 1H; CH); 13C NMR ([D6]DMSO, 75 MHz): d=17.5,
21.2, 50.7, 127.3, 127.6, 130.3, 137.4, 137.7, 138.3, 142.5, 144.7, 160.3 ppm.
0.075 mmol, 1.0 equiv), KOtBu (17 mg, 0.15 mmol, 2.0 equiv), and N,N’-
bis(2,4,6-trimethylphenyl)imidazolinium chloride (46 mg, 0.135 mmol,
1.8 equiv). Workup procedure A was followed. Yield: 62 mg (72%).
1H NMR (CDCl3, 300 MHz): d=1.18–1.34 (m, 4H; cod CH2), 1.59–1.62
(m, 4H; cod CH2), 2.31 (s, 6H; CH3), 2.34 (s, 6H; CH3), 2.55 (s, 6H;
CH3), 3.07 (m, 2H; cod CH), 3.90 (s, 4H; NCH2CH2N), 4.09 (m, 2H; cod
CH), 6.94 (s, 2H; arom.), 6.97 ppm (s, 2H; arom.); 13C NMR (CDCl3,
75 MHz): d=17.4, 18.8, 20.0, 27.6, 32.4, 50.4, 50.8, 82.7, 127.3, 128.8,
134.2, 135.2, 136.7, 137.0, 206.3 ppm.
A
(cod)
U
U
U
General procedure for the synthesis of [IrCl
A
G
0.075 mmol, 1.0 equiv), KOtBu (17 mg, 0.15 mmol, 2.0 equiv), and N,N’-
bis(2,4,6-trimethylphenyl)imidazolium chloride (46 mg, 0.135 mmol,
1.8 equiv). Workup procedure A was followed. Yield: 80 mg (93%);
1H NMR (CDCl3, 300 MHz): d=1.18–1.34 (m, 4H; cod CH2), 1.61–1.70
(m, 4H; cod CH2), 2.16 (s, 6H; CH3), 2.36 (s, 6H; CH3), 2.36 (s, 6H;
CH3), 2.97 (m, 2H; cod CH), 4.15 (m, 2H; cod CH), 6.95 (s, 2H;
NCHCHN), 6.98 (s, 2H; arom.), 7.04 ppm (s, 2H; arom.); 13C NMR
(CDCl3, 75 MHz): d=17.2, 18.6, 20.1, 27.9, 32.5, 50.4, 81.5, 122.3, 127.1,
128.5, 133.4, 135.1, 136.3, 137.6, 179.8 ppm.
A
ACHTREUNG
tube, dissolved in THF (5 mL) under an atmosphere of Ar and stirred for
10 min at room temperature. To this mixture was added the correspond-
ing azolium salt (1.8 equiv). The reaction mixture was stirred for 2 h at
room temperature and the solvent was evaporated in vacuo.
Workup A: The residue was dissolved in diethyl ether and purified by
column chromatography using diethyl ether as an eluent. The product
was obtained as a yellow powder.
Workup B: The residue was washed with diethyl ether (3 mL), dissolved
in CH2Cl2, and filtrated over Celite. The solvent was evaporated in vacuo
leaving a yellow powder.
A
G
(16s)]: Starting materials used were [Ir
G
E
0.075 mmol, 1.0 equiv), KOtBu (17 mg, 0.15 mmol, 2.0 equiv), and N,N’-
bis(2,6-dimethylphenyl)imidazolinium chloride (43 mg, 0.135 mmol,
1.8 equiv). Workup procedure A was followed. Yield: 75 mg (90%);
1H NMR (CDCl3, 300 MHz): d=1.18–1.33 (m, 4H; cod CH2), 1.54–1.63
(m, 4H; cod CH2), 2.40 (s, 6H; CH3), 2.59 (s, 6H; CH3), 3.05 (m, 2H;
cod CH), 3.94 (s, 4H; NCH2CH2N), 4.09 (m, 2H; cod CH), 7.23 (s, 6H;
arom.), 7.25 ppm (s, 6H; arom.); 13C NMR (CDCl3, 75 MHz): d=17.6,
19.0, 27.6, 32.4, 50.5, 50.6, 83.1, 126.7, 127.2, 128.1, 134.6, 137.5, 137.6,
206.2 ppm.
A
(cod)
U
U
U
0.075 mmol, 1.0 equiv), KOtBu (17 mg, 0.15 mmol, 2.0 equiv), and N,N’-
bis(2,6-dimethyl-4-diethylaminophenyl)imidazolinium chloride (62 mg,
0.135 mmol, 1.8 equiv). Workup procedure A was followed. Yield: 78 mg
(76%); 1H NMR (CDCl3, 300 MHz): d=1.14–1.28 (m, 4H; cod CH2),
1.14–1.19 (m, 12H; CH3), 1.61–1.66 (m, 4H; cod CH2), 2.32 (s, 6H; CH3),
2.53 (s, 6H; CH3), 3.17 (m, 2H; cod CH), 3.30–3.41 (q, 8H; NCH2), 3.87
(s, 4H; NCH2CH2N), 4.06 (m, 2H; cod CH), 6.40 (d, 2H; arom.),
6.43 ppm (d, 2H; arom.); 13C NMR (CDCl3, 75 MHz): d=11.6, 18.2, 19.4,
27.7, 32.5, 43.4, 50.0, 51.2, 81.2, 109.6, 111.0, 126.6, 135.0, 137.9, 146.1,
207.0 ppm.
G
G
E
1.8 equiv). Workup procedure A was followed. Yield: 69 mg (82%);
1H NMR (CDCl3, 500 MHz): d=1.23–1.27 (m, 2H; cod CH2), 1.32–1.35
(m, 2H; cod CH2), 1.63–1.70 (m, 4H; cod CH2), 2.21 (s, 6H; CH3), 2.40
(s, 6H; CH3), 2.95 (m, 2H; cod CH), 4.15 (m, 2H; cod CH), 7.00 (s, 2H;
NCHCHN), 7.18 (m, 6H; arom.), 7.31 ppm (s, 6H; arom.); 13C NMR
A
(cod)
U
U
U
0.075 mmol, 1.0 equiv), KOtBu (17 mg, 0.15 mmol, 2.0 equiv) and N,N’-
bis(2,6-dimethyl-4-diethylaminophenyl)imidazolium chloride (61 mg,
0.135 mmol, 1.8 equiv). Workup procedure A was followed. Yield: 70 mg
Chem. Eur. J. 2007, 13, 7195 –7203
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7201